Reem Almasri - العربية

A groundbreaking light-based biopotential sensing system that redefines traditional wired methods such as ECG, EEG, and ECoG for monitoring bioelectrical signals in the body. The technology utilizes novel liquid crystals—commonly found in LCD screens and industrial electronics—to detect bioelectrical activity by directly and linearly altering light reflectance, enabling high-resolution signal capture without electrical wires, bulky hardware, chemicals, or gene transfers. Optical fibers transmit these signals from hundreds of channels in real time, ensuring high fidelity with minimal noise or interference. The flexible, conforming design seamlessly adheres to irregular organ surfaces, enabling stable and precise signal monitoring during natural movement (e.g., heartbeats). Developed by Reem's startup, this transformative technology has the potential to revolutionize the field of electrophysiology by advancing preclinical research, enhancing clinical diagnostics for conditions like epilepsy, Parkinson’s, and arrhythmias, and enabling next-generation brain-machine interfacing. This patented technology is advancing cardiac and neural applications in the form of a minimally invasive flexible implant. For cardiac applications, it precisely monitors bio-electrical activity to diagnose arrhythmias like atrial fibrillation by optically mapping chaotic events across wide tissue areas during rhythm disorders.